Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-05-14T16:20:55.169Z Has data issue: false hasContentIssue false

Obesity and loss of ambulation are associated with lower extremity oedema in Duchenne muscular dystrophy

Published online by Cambridge University Press:  13 May 2022

Joshua M Freytag
Affiliation:
Heart Institute Research Core, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Thomas D Ryan
Affiliation:
Heart Institute, Cincinnati Children’s Hospital Medical Center Location C, Cincinnati, OH, USA Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Jean E Bange
Affiliation:
Division of Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Kelly C Bonarrigo
Affiliation:
Division of Occupational Therapy and Physical Therapy, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Wendy A Chouteau
Affiliation:
Division of Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Samuel G Wittekind
Affiliation:
Heart Institute, Cincinnati Children’s Hospital Medical Center Location C, Cincinnati, OH, USA Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Cuixia Tian
Affiliation:
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA Division of Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Zhiqian Gao
Affiliation:
Heart Institute Research Core, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
Chet R Villa*
Affiliation:
Heart Institute, Cincinnati Children’s Hospital Medical Center Location C, Cincinnati, OH, USA Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
*
Author for correspondence: Chet R Villa, MD, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, MLC 2003, Cincinnati, OH 45229, USA. Tel: +1 (513) 803 1428; Fax: 513-803-0564. E-mail: Chet.Villa@cchmc.org

Abstract

Patients with Duchenne muscular dystrophy have multiple risk factors for lower extremity oedema. This study sought to define the frequency and predictors of oedema. Patients aged 15 years and older were screened by patient questionnaire, and the presence of oedema was confirmed by subsequent physical exam. Twenty-four of 52 patients (46%) had oedema, 12 of whom had swelling extending above the foot and two with sores/skin breakdown. There was no significant difference in age, frequency, or duration of glucocorticoid use, non-invasive respiratory support use, forced vital capacity, cardiac medication use, or ejection fraction between patients with and without oedema (all p > 0.2). Those with oedema had a greater time since the loss of ambulation (8.4 years versus 3.5 years; p = 0.004), higher body mass index (28.3 versus 24.8; p = 0.014), and lower frequency of deflazacort use (67% versus 89%; p = 0.008). Multivariate analysis revealed a longer duration of loss of ambulation (p = 0.02) and higher body mass index (p = 0.009) as predictors of oedema. Lower extremity oedema is common in Duchenne muscular dystrophy but independent of cardiac function. Interventions focused on minimising body mass index increases over time may be a therapeutic target.

Type
Original Article
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Landfeldt, E, Thompson, R, Sejersen, T, McMillan, HJ, Kirschner, J and Lochmuller, H. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. European journal of epidemiology 2020; 35: 643653.CrossRefGoogle ScholarPubMed
McDonald, CM, Henricson, EK, Abresch, RT, et al. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet 2018; 391: 451461.CrossRefGoogle ScholarPubMed
Sawnani, H, Horn, PS, Wong, B, et al. Comparison of pulmonary function decline in steroid-treated and steroid-naive patients with Duchenne muscular dystrophy. J Pediatr 2019; 210: 194200 e2.CrossRefGoogle ScholarPubMed
Birnkrant, DJ, Bushby, K, Bann, CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018; 17: 251267.CrossRefGoogle ScholarPubMed
Greene, AK and Sudduth, CL. Lower extremity lymphatic function in nonambulatory patients with neuromuscular disease. Lymphat Res Biol 2021; 19: 126128.CrossRefGoogle ScholarPubMed
Scallan, JP, Zawieja, SD, Castorena-Gonzalez, JA and Davis, MJ. Lymphatic pumping: mechanics, mechanisms and malfunction. J Physiol 2016; 594: 57495768.CrossRefGoogle ScholarPubMed
Schad, H and Brechtelsbauer, H. Thoracic duct lymph flow and composition in conscious dogs and the influence of anaesthesia and passive limb movement. Pflugers Arch 1977; 371: 2531.CrossRefGoogle ScholarPubMed
Greene, AK, Grant, FD and Slavin, SA. Lower-extremity lymphedema and elevated body-mass index. N Engl J Med 2012; 366: 2136–7.CrossRefGoogle ScholarPubMed
Gauld, LM, Kappers, J, Carlin, JB and Robertson, CF. Height prediction from ulna length. Dev Med Child Neurol 2004; 46: 475–80.CrossRefGoogle ScholarPubMed
Rabe, E, Partsch, H, Hafner, J, et al. Indications for medical compression stockings in venous and lymphatic disorders: an evidence-based consensus statement. Phlebology 2018; 33: 163184.CrossRefGoogle ScholarPubMed
Nose, Y, Murata, K, Wada, Y, et al. The impact of intermittent pneumatic compression devices on deep venous flow velocity in patients with congestive heart failure. J Cardiol 2010; 55: 384–90.CrossRefGoogle ScholarPubMed
Leduc, O, Crasset, V, Leleu, C, et al. Impact of manual lymphatic drainage on hemodynamic parameters in patients with heart failure and lower limb edema. Lymphology 2011; 44: 1320.Google ScholarPubMed
Urbanek, T, Jusko, M and Kuczmik, WB. Compression therapy for leg oedema in patients with heart failure. ESC heart failure 2020; 7: 20122020.CrossRefGoogle ScholarPubMed
Henson, SE, Lang, SM, Khoury, PR, et al. The effect of adiposity on cardiovascular function and myocardial fibrosis in patients with Duchenne muscular dystrophy. J Am Heart Assoc 2021; 10: e021037.CrossRefGoogle ScholarPubMed
Brumbaugh, D, Watne, L, Gottrand, F, et al. Nutritional and gastrointestinal management of the patient with Duchenne muscular dystrophy. Pediatrics 2018; 142: S53S61.CrossRefGoogle ScholarPubMed
Chew, K, Carey, K, Ho, G, Mallitt, KA, Widger, J and Farrar, M. The relationship of body habitus and respiratory function in Duchenne muscular dystrophy. Respir Med 2016; 119: 3540.CrossRefGoogle ScholarPubMed
Inge, TH, King, WC, Jenkins, TM, et al. The effect of obesity in adolescence on adult health status. Pediatrics 2013; 132: 1098–104.CrossRefGoogle ScholarPubMed
Burian, EA, Karlsmark, T, Franks, PJ, Keeley, V, Quéré, I and Moffatt, CJ. Cellulitis in chronic oedema of the lower leg: an international cross-sectional study. Br J Dermatol 2021; 185: 110118.CrossRefGoogle ScholarPubMed
Vasileiou, AM, Bull, R, Kitou, D, Alexiadou, K, Garvie, NJ and Coppack, SW. Oedema in obesity; role of structural lymphatic abnormalities. International Journal of Obesity 2011; 35: 12471250.CrossRefGoogle ScholarPubMed
Mehmood, M, Ambach, SA, Taylor, MD, et al. Relationship of right ventricular size and function with respiratory status in Duchenne muscular dystrophy. Pediatr Cardiol 2016; 37: 878–83.CrossRefGoogle ScholarPubMed
Supplementary material: File

Freytag et al. supplementary material

Freytag et al. supplementary material

Download Freytag et al. supplementary material(File)
File 61.5 KB